www.retinsight.com Open in urlscan Pro
2a05:d014:1b99:2600:9b9c:9715:e0c:2a8e  Public Scan

Form analysis
1 forms found in the DOM

GET https://www.retinsight.com/

<form role="search" method="get" class="search search-form" action="https://www.retinsight.com/">
  <label>
    <span class="screen-reader-text">Search</span>
  </label>
  <input type="search" class="search-field" placeholder="Search" value="" name="s" title="Suche">
  <button type="button" class="searchclose" tabindex="-1">
    <span></span>
  </button>
  <button type="submit" class="searchsubmit" value="Search">
    <span></span>
  </button>
</form>

Text Content

We value your privacy

We use cookies to enhance your browsing experience, like playing embedded videos
and other third-party features. Cookie & Privacy Policy

Customize Reject All Accept All
Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions.
You will find detailed information about all cookies under each consent category
below.

The cookies that are categorized as "Necessary" are stored on your browser as
they are essential for enabling the basic functionalities of the site. ... Show
more

NecessaryAlways Active

Necessary cookies are required to enable the basic features of this site, such
as providing secure log-in or adjusting your consent preferences. These cookies
do not store any personally identifiable data.

 * Cookie
   cookieyes_consent
 * Duration
   30 Days
 * Description
   
   Speichert den Zustimmungsstatus des Benutzers für Cookies auf der aktuellen
   Website.

Functional


Functional cookies help perform certain functionalities like playing embedded
videos, collecting feedback, and other third-party features.

 * Cookie
   __cf_bm
 * Duration
   1 Day
 * Description
   
   Dieser Cookie wird verwendet, um zwischen Menschen und Bots zu unterscheiden.

 * Cookie
   _cfuvid
 * Duration
   Session
 * Description
   
   Dieses Cookie trägt zur Performance des eingebetteten Videos bei.

 * Cookie
   vuid
 * Duration
   2 years
 * Description
   
   Saves user data about their video interaction.

 * Cookie
   player
 * Duration
   1 year
 * Description
   
   Saves user settings about playing embedded videos.

Reject All Save My Preferences Accept All



RETINSIGHT - BRINGING AI TO THE EYE IN 1010 VIENNA - AUSTRIA

 * Overview
 * AI in Clinical Routine
   * GA Monitor
   * Fluid Monitor
 * AI in Clinical Studies
   * AI in GA
   * AI in nAMD, DME, RVO
 * Company
   * About RetInSight
   * Our Team
   * Dedication to Compliance
   * Career
   * Contact
 * Science & Technology
 * Newsroom
   * News
   * Events
 * Request a Demo
 * Search
 * DE

RetInSight


FROM IMAGE TO INSIGHT



Your partner in advancing ophthalmology with AI




RetInSight


FROM IMAGE TO INSIGHT



Your partner in advancing ophthalmology with AI




RetInSight


FROM IMAGE TO INSIGHT



Your partner in advancing ophthalmology with AI




RetInSight


FROM IMAGE TO INSIGHT



Your partner in advancing ophthalmology with AI




RetInSight


FROM IMAGE TO INSIGHT



Your partner in advancing ophthalmology with AI




RetInSight


FROM IMAGE TO INSIGHT



Your partner in advancing ophthalmology with AI






RetInSight empowers eye care providers and professionals, academic institutions,
and the eye care industry to reimagine clinical care with our advanced
artificial intelligence solutions.

We leverage data to deliver novel insights into unmet diagnostic needs
associated with diseases that manifest in the retina.




Our Solutions & Services


EXPLORE OUR ADVANCED SOLUTIONS



RETINSIGHT GA MONITOR

Revolutionize the management of Geographic Atrophy (GA) with our AI-driven GA
Monitor. Accurate disease assessment and treatment evaluation at your
fingertips.



learn more



RETINSIGHT FLUID MONITOR

Stay ahead in the battle against neovascular Age-Related Macular Degeneration
(nAMD). Our Fluid Monitor leverages AI for precise fluid quantification and
treatment response analysis.



learn more



CLINICAL STUDIES

Join us in shaping the future of retinal healthcare through collaborative
clinical research. Discover the potential of AI in advancing scientific
knowledge.



learn more







WHAT OUR CUSTOMERS ARE SAYING ABOUT THE RETINSIGHT SOLUTIONS




"Integrating the Fluid Monitor into my daily clinical routine allowed me to
increase efficiency, relieves me from repetitive work, improves quality control
and finally gives me back more time for treatment interventions of my patients."

Dr. Vincent Gualino
Clinique Honoré Cave, Montauban, Occitanie, France

„Es kann Dinge messen, die wir bisher gar nicht erfasst haben. ... Mit der
Software vermag ich viel genauer zu bestimmen, wann ich mit einer Behandlung
beginne.“

(Translated into English: "It can measure things that we have not captured
before. ... With the software, I can determine much more accurately when I start
a treatment.")

Prof. Dr. med. Ulrich Kellner (Statement taken from FOCUS Magazin Article)
AugenZentrum Siegburg, Siegburg, Germany

"Der "Impact" auf die tägliche Arbeit ist enorm! Eine völlig neue Dimension der
Betreuung der Makulapatienten."

(Translated into English: "The impact on daily practice is enormous! A
completely new dimension in the care of macula patients.")

Prof. Dr. med. Joachim E. Nasemann
Makula Netzhaut Zentrum München, Munich, Germany

"Integrating the Fluid Monitor into my daily clinical routine allowed me to
increase efficiency, relieves me from repetitive work, improves quality control
and finally gives me back more time for treatment interventions of my patients."

Dr. Vincent Gualino
Clinique Honoré Cave, Montauban, Occitanie, France

„Es kann Dinge messen, die wir bisher gar nicht erfasst haben. ... Mit der
Software vermag ich viel genauer zu bestimmen, wann ich mit einer Behandlung
beginne.“

(Translated into English: "It can measure things that we have not captured
before. ... With the software, I can determine much more accurately when I start
a treatment.")

Prof. Dr. med. Ulrich Kellner (Statement taken from FOCUS Magazin Article)
AugenZentrum Siegburg, Siegburg, Germany

"Der "Impact" auf die tägliche Arbeit ist enorm! Eine völlig neue Dimension der
Betreuung der Makulapatienten."

(Translated into English: "The impact on daily practice is enormous! A
completely new dimension in the care of macula patients.")

Prof. Dr. med. Joachim E. Nasemann
Makula Netzhaut Zentrum München, Munich, Germany

"Integrating the Fluid Monitor into my daily clinical routine allowed me to
increase efficiency, relieves me from repetitive work, improves quality control
and finally gives me back more time for treatment interventions of my patients."

Dr. Vincent Gualino
Clinique Honoré Cave, Montauban, Occitanie, France








Our Platform


HOW IT WORKS



We develop and deliver our solutions and services on a comprehensive and
flexible Al platform, and offer cloud-based Al modules tailored to your needs:
Stand-alone, device integration, and PACS integration

 

Explore our AI Solutions for Clinical Routine Explore our AI Solutions for
Clinical Studies






Our Company


WE ARE ONE TEAM WITH ONE GOAL:
BRINGING AI TO THE EYE



As a spin-off of the Medical University of Vienna, we stand on a foundation of
over a decade of global academic leadership in AI-based retinal image analysis.

Our interdisciplinary team embodies competence, experience, and innovation, as
we are united by one goal: Preserve eyesight throughout lifetime – by bringing
AI to the eye.

learn more







News


NEWS & INSIGHTS



ARTICLE IN FOCUS MAGAZIN: “THE GREAT MEDICAL REVOLUTION: FASTER DIAGNOSES,
BETTER THERAPIES – THE OPPORTUNITIES OF ARTIFICIAL INTELLIGENCE"

08 2024   RetInSight is revolutionizing diagnosis and therapy in medicine with
AI technology. In ophthalmology, our software enables precise diagnosis of
age-related macular degeneration (AMD) and helps determine the optimal timing
for treatments. Learn more about how we’re transforming healthcare and
fulfilling the...



PRESS RELEASE: RETINSIGHT AND VEONET LAUNCH COMPREHENSIVE COLLABORATION TO
IMPROVE AMD CARE

07 2024 Vienna, 2024, July 10th – RetInSight, a pioneer in AI-based image
analysis of retinal diseases, and veonet, a leading network of ophthalmology
care centers in several countries, including Germany, Switzerland, and the UK,
have entered into a commercial agreement. This agreement allows veonet to
integrate...



PRESS RELEASE: REVOLUTIONISING EYE HEALTH: I-SCREEN PROJECT INTEGRATES AI FOR
EARLY DETECTION OF AGE-RELATED MACULAR DEGENERATION

03 2024   Leading the charge in redefining eye care, the innovative I-SCREEN
project is tackling age-related macular degeneration (AMD), the predominant
cause of severe vision loss in individuals aged 55 and above. [Wien, 20 March
2024] – With a mission to transform eye care, the I-SCREEN project is pioneering
an...



INTERVIEW: ARTIFICIAL INTELLIGENCE (AI) IN THE MANAGEMENT OF RETINAL DISEASES

01 2024 In this episode of the IEMO VideoPodcast, Prof. Paolo Lanzetta is
interviewing Prof. Ursula Schmidt-Erfurth on Artificial Intelligence (AI) and
how it will bring about transformative changes in every field of science,
research, industry and society.






RETINSIGHT GMBH

Elisabethstraße 13/1/13
1010 Vienna - Austria



CONTACT

contact@retinsight.com
+43 1 5813 881



CAREER

career@retinsight.com
Job Opportunities




 * © 2024 RetInSight GmbH

 * Privacy
 * Legal information



designtiger webdesign wien



 * Overview
 * AI in Clinical Routine
   
   * GA Monitor
   * Fluid Monitor
 * AI in Clinical Studies
   
   * AI in GA
   * AI in nAMD, DME, RVO
 * Company
   
   * About RetInSight
   * Our Team
   * Dedication to Compliance
   * Career
   * Contact
 * Science & Technology
 * Newsroom
   
   * News
   * Events
 * Request a Demo
 * Search
 * DE










Search